Small Molecules
13 July 2018
Termination of License and Development Agreement for “OBLEAN® Tablets 120mg” for Treatment of Obesity10 July 2018
VALBIOTIS Announces Positive Results from First Phase I/II Clinical Study of VAL-070 in Hypercholesterolemia10 July 2018
Aeromics Initiates Phase 1 Clinical Trial of CNS Edema Inhibitor AER-271 In Healthy Human Volunteers10 July 2018
BELLUS Health Initiates Phase 1 Clinical Study for its Chronic Cough Drug Candidate, BLU-59376 July 2018
Orion has started a Phase III trial to develop a drug for ALS – The patient recruitment has begun5 July 2018
Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 StudyNews Channels
Newsletter
La Merie Biologics
La Merie Publishing releases a weekly newsletter with a focus on biopharmaceutical research and development.
SubscribeNewsletter
New Product Alert
La Merie Publishing offers an e-mail notification service about the release of new products of La Merie Publishing. This New Product Release Alert also informs about the release of FREE reports produced by La Merie Publishing.
SubscribeFeatured reports